As a Ph.D. candidate in the Smith School of Chemical and Biomolecular Engineering, Nathan Piligian is developing a novel ...
Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.